Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low dose heparin and early kidney transplant function

J S Horvath, D J Tiller, G G Duggin

    Australian and New Zealand Journal of Medicine
    |December 1, 1975
    PubMed
    Summary

    Subcutaneous heparin (Calciparine) at subanticoagulant doses did not improve early renal allograft function in a randomized trial. This treatment also increased the risk of hemorrhagic complications compared to placebo.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The morning blood pressure surge is related to serum cholesterol.

    Journal of human hypertension·2012
    Same author

    Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.

    Internal medicine journal·2010
    Same author

    Exchanges across land-water-scape boundaries in urban systems: strategies for reducing nitrate pollution.

    Annals of the New York Academy of Sciences·2008
    Same author

    Is venous reflux a common disease in post-thrombotic patients with unilateral deep vein thrombosis episode?

    Phlebology·2008
    Same author

    Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.

    The Journal of clinical endocrinology and metabolism·2005
    Same author

    Vascular dysfunction and metabolic parameters in polycystic ovary syndrome.

    The Journal of clinical endocrinology and metabolism·2005

    Area of Science:

    • Nephrology
    • Transplantation immunology
    • Pharmacology

    Background:

    • Early renal allograft function is crucial for patient outcomes.
    • Subanticoagulant doses of heparin are sometimes used to prevent thrombosis.
    • The impact of low-dose heparin on early graft function requires clarification.

    Purpose of the Study:

    • To evaluate the efficacy of subcutaneous heparin in improving early renal allograft function.
    • To assess the safety profile of subanticoagulant heparin doses in kidney transplant recipients.

    Main Methods:

    • Prospective, randomized, double-blind, placebo-controlled trial.
    • 36 patients undergoing kidney transplantation were randomized to receive either heparin or placebo.
    • Early graft function, rejection episodes, and hemorrhagic complications were monitored.

    Related Experiment Videos

    Main Results:

    • No significant difference in early graft function between heparin and placebo groups.
    • Similar rates of rejection episodes and treatment responses were observed.
    • Four patients in the heparin group experienced hemorrhagic complications, versus none in the placebo group.

    Conclusions:

    • Subanticoagulant doses of subcutaneous heparin do not demonstrably improve early renal allograft function.
    • Low-dose heparin may increase the risk of hemorrhagic complications in kidney transplant patients.